Oncimmune Holdings plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by John Goold, was filed 11 Nov 2024.
Oncimmune Holdings plc: what insiders have been doing
Every trade that managers of Oncimmune Holdings plc disclose to RNS (LSE) is tracked on this page. Oncimmune Holdings plc has had no insider filing for more than a year; the last one goes back to 11 November 2024.
Since 2017, the database holds 6 purchases and no sales by insiders of the company.
Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 589,971 shares@ £0.169510.5% of flowOutside a trading venueISIN GB00BYQ94H38RNS:5424771-3
- 105,263 shares@ £0.2665.3% of flowOutside a trading venueISIN GB00BYQ94H38RNS:5424771-4
- 5,588,661 shares@ £0.1588.4% of flowOutside a trading venueISIN GB00BYQ94H38RNS:5424771-5
- 3,353,197 shares@ £0.1594.7% of flowOutside a trading venueISIN GB00BYQ94H38RNS:5424771-6
- 100,000 shares@ £0.15100.0% of flowAIM, London Stock Exchange (XLON)ISIN GB00BYQ94H38RNS:5424771-0Canonical exit: 21 Jan 2025 (T+90)
- 66,667 shares@ £0.151.1% of flowAIM, London Stock Exchange (XLON)ISIN GB00BYQ94H38RNS:5424771-1Canonical exit: 21 Jan 2025 (T+90)
- 333,333 shares@ £0.15100.0% of flowAIM, London Stock Exchange (XLON)ISIN GB00BYQ94H38RNS:5424771-2Canonical exit: 21 Jan 2025 (T+90)
- 36,023 shares@ £0.2725100.0% of flowLondon Stock Exchange, AIMXRNS:4999190Canonical exit: 7 Mar 2024 (T+90)
- 48,370 shares@ £0.2065100.0% of flowLondon Stock Exchange, AIMXRNS:4792314Canonical exit: 3 Sept 2023 (T+90)
- 1,955,555 sharesOutside a trading venueISIN GB00BYQ94H38FCA-NSM:4617349
- 12,287 shares@ £0.85100.0% of flowLondon stock exchange, AIMISIN GB00BYQ94H38FCA-NSM:3573898Canonical exit: 23 Jul 2020 (T+90)
- 300,000 sharesN/AISIN GB00BYQ94H38FCA-NSM:LSE20171027103221_13411597_20200330131538207_18919-0
- 30,000 sharesN/AISIN GB00BYQ94H38FCA-NSM:LSE20171027103221_13411597_20200330131538207_18919-1
13 of 13 declarations
About Oncimmune Holdings plc
Oncimmune Holdings plc is a biotechnology company focused on developing diagnostic tests for cancer. It specializes in identifying immune biomarkers to enhance cancer screening and treatment.
